MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis

Table 1

Study characteristics for the included studies.

Author; (year, country)	Samples	Median age (range)	M/F	Adequacy of evaluating MUC1 expression	Study period	Median follow-up (months)	NOS score
Akyürek et al. [13]; (2002, Germany)	143	NS	94/49	Yes	NS	30 (2–80)	9
Barresi et al. [14]; (2006, Italy)	40	69.4 (54–77)	23/17	Yes	NS	NS	9
Ilhan et al. [9]; (2010, Turkey)	257	NS	201/56	Yes	2000–2007	NS	8
Kocer et al. [12]; (2004, Turkey)	44	59.7 (27–77)	31/13	Yes	1996–2001	25 (1–79)	7
Lee et al. [11]; (2001, Korea)	59	NS	56/17	Yes	1995-1995	42 (1–60)	9
Ohno et al. [15]; (2006, Japan)	202	63	142/60	Yes	1993–2000	NS	9
Reis et al. [16]; (1998, UK)	180	NS	105/75	Yes	NS	NS	8
Wang et al. [17]; (2003, China)	76	65 (32–84)	52/24	Yes	1996–1998	30 (1–58)	7
Wang and Fang [18]; (2003, China)	46	54.6 (30–70)	34/12	Yes	NS	NS	8
Zhang et al. [10]; (2004, China)	94	52.1 (25–75)	64/30	Yes	1989–2000	NS	8

NA: not available, M/F: male/female, and NOS: Newcastle-Ottawa Scale.